Palvella Therapeutics Inc [PVLA] stock is trading at $99.73, down -4.09%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PVLA shares have gain 7.92% over the last week, with a monthly amount glided 3.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Palvella Therapeutics Inc [NASDAQ: PVLA] stock has seen the most recent analyst activity on January 07, 2026, when Mizuho initiated its Outperform rating and assigned the stock a price target of $205. Previously, BTIG Research started tracking the stock with Buy rating on December 05, 2025, and set its price target to $167. On December 04, 2025, Craig Hallum initiated with a Buy rating and assigned a price target of $175 on the stock. Raymond James upgraded its rating to a Strong Buy but stick to its price target of $143 on November 19, 2025. Oppenheimer initiated its recommendation with a Outperform and recommended $85 as its price target on September 09, 2025. Raymond James started tracking with a Outperform rating for this stock on August 06, 2025, and assigned it a price target of $54. In a note dated July 21, 2025, Truist initiated an Buy rating and provided a target price of $56 on this stock.
Palvella Therapeutics Inc [PVLA] stock has fluctuated between $12.10 and $114.69 over the past year. Currently, Wall Street analysts expect the stock to reach $185.92 within the next 12 months. Palvella Therapeutics Inc [NASDAQ: PVLA] shares were valued at $99.73 at the most recent close of the market. An investor can expect a potential return of 86.42% based on the average PVLA price forecast.
Analyzing the PVLA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.49, Equity is -0.64 and Total Capital is -0.56.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Palvella Therapeutics Inc’s Current Ratio is 6.49. As well, the Quick Ratio is 6.49, while the Cash Ratio is 6.16.
Transactions by insiders
Recent insider trading involved Goin Kathleen, Chief Operating Officer, that happened on Dec 17 ’25 when 4302.0 shares were sold. Officer, Goin Kathleen completed a deal on Dec 17 ’25 to buy 4302.0 shares. Meanwhile, Chief Operating Officer Goin Kathleen sold 4302.0 shares on Nov 19 ’25.
